Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio WEST LAFAYETTE, Ind., July 12, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...

Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius® 2,000-Liter Single-Use Bioreactors in Its Myford Facility -- Bioreactors Now Online and Able to Meet Needs of Current and Future Clients -- -- State-of-the-Art Myford Facility Features Industry-Leading Flexibility, Scalability and Ease-of-Use -- TUSTIN,...